{{Rsnum
|rsid = 28930068
|Gene = CACNA1S
|Orientation=minus
|ReferenceAllele=G
|MissenseAllele=A
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
|Chromosome=1
|position=201053538
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|Gene_s=CACNA1S
}}{{omim
|desc=HYPOKALEMIC PERIODIC PARALYSIS
|id=114208
|rsnum=28930068
|variant=0001
}}
{{ neighbor
| rsid = 28930069
| distance = 1
}}

{{ClinVar
|rsid=28930068
|Reversed=1
|FwdREF=G
|FwdALT=A
|REF=C
|ALT=T
|RSPOS=201053538
|CHROM=1
|dbSNPBuildID=131
|SSR=0
|SAO=1
|VP=0x050168000a05000002110100
|GENEINFO=CACNA1S:779
|GENE_NAME=CACNA1S
|GENE_ID=779
|WGT=1
|VC=SNV
|CLNALLE=1
|CLNHGVS=NC_000001.11:g.201053538C>T
|CLNSRC=ClinVar; GeneReviews; OMIM Allelic Variant
|CLNORIGIN=1
|CLNSRCID=NM_000069.2:c.3716G>A; NBK1338; 114208.0001
|CLNSIG=5
|CLNCUI=CN031165; CN031165
|CLNDBN=Hypokalemic periodic paralysis 1
|Disease=Hypokalemic periodic paralysis 1
|CLNACC=RCV000019190.26
|Tags=RV;PM;PMC;SLO;NSM;REF;ASP;OTHERKG;LSD;OM
|CLNDSDB=GeneReviews:GeneReviews:MedGen:OMIM:Orphanet
|CLNDSDBID=NBK1338:NBK1496:CN031165:170400:ORPHA681
}}

{{PMID Auto
|PMID=3037387
|Title=Primary structure of the receptor for calcium channel blockers from skeletal muscle.
}}

{{PMID Auto
|PMID=7847370
|Title=Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families.
|OA=1
}}

{{PMID Auto
|PMID=8004673
|Title=Dihydropyridine receptor mutations cause hypokalemic periodic paralysis.
}}

{{PMID Auto
|PMID=11353725
|Title=Hypokalaemic periodic paralysis type 2 caused by mutations at codon 672 in the muscle sodium channel gene SCN4A.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}